Zalutumumab plus best supportive care versus best supportive care alone in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck after failure of platinum-based chemotherapy: an open-label, randomised phase 3 trial-Reference-Cited by-同舟云学术

Zalutumumab plus best supportive care versus best supportive care alone in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck after failure of platinum-based chemotherapy: an open-label, randomised phase 3 trial

Published:2011-04 Issue:4 Volume:12 Page:333-343
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Machiels Jean-Pascal,Subramanian Somasundaram,Ruzsa Agnes,Repassy Gabor,Lifirenko Igor,Flygare Annika,Sørensen Per,Nielsen Tina,Lisby Steen,Clement Paul MJ

Publisher

Elsevier BV

Subject

Oncology

Reference32 articles.

1. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008;Ferlay;Int J Cancer,2010

2. Head and neck cancer;Vokes;N Engl J Med,1993

3. Platinum-based chemotherapy plus cetuximab in head and neck cancer;Vermorken;N Engl J Med,2008

4. Primary efficacy and safety results of SPECTRUM, a phase 3 trial in patients (pts) with recurrent and/or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN) receiving chemotherapy with or without panitumumab (PMAB);Vermorken;Ann Oncol,2010

5. Dual mode of action of a human anti-epidermal growth factor receptor monoclonal antibody for cancer therapy;Bleeker;J Immunol,2004

Cited by 212 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Therapeutic Implications of Co-Targeting the EGFR and Spindle Assembly Checkpoint Pathways in Oral Cancer;Pharmaceutics;2024-09-11

2. Frequency of use and cost in Japan of first-line palliative chemotherapies for recurrent or metastatic squamous cell carcinoma of the head and neck;Japanese Journal of Clinical Oncology;2024-08-29

3. Induction chemotherapy with paclitaxel, carboplatin, and cetuximab (PCE) followed by chemoradiotherapy for unresectable locoregional recurrence after curative surgery in patients with squamous cell carcinoma of the head and neck;Frontiers in Oncology;2024-07-01

4. Molecular pathways and targeted therapies in head and neck cancers pathogenesis;Frontiers in Oncology;2024-06-17

5. Role of EGFR and FASN in breast cancer progression;Journal of Cell Communication and Signaling;2023-07-25